NCT04921514

Brief Summary

This study will evaluate and describe the occurrence of Acute traumatic stress and persistence of Post Traumatic Stress Disorder (PTSD) after resuscitated sudden cardiac death (SCD) in patient and relatives present during the event. The population will be composed of 40 patients: 20 with resuscitated SCD and 20 relatives. Two interviews will be performed by a psychologist within one week after resuscitated SCD and at month 3. Questionnaire Stanford Acute Stress Reaction Questionnaire (SASRQ), Life Events Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (LEC-5) and Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) will be filled during these interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2021

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2022

Completed
Last Updated

June 17, 2025

Status Verified

June 1, 2025

Enrollment Period

1.4 years

First QC Date

June 4, 2021

Last Update Submit

June 12, 2025

Conditions

Keywords

Sudden cardiac death

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients and relatives with PTSD at months 3 post resuscitated SCD

    The percentage of patients and relatives is determined using the PCL-5 and LEC-5 questionnaire

    Month 3

Secondary Outcomes (2)

  • Proportion of patients and/or relatives with acute stress disorder

    Day 0

  • Proportion of patients and/or relatives with trauma vulnerability

    Month3

Study Arms (1)

Patient and relatives

EXPERIMENTAL
Behavioral: SASRQ questionnaireBehavioral: PCL-5 with LEC-5 questionnaire

Interventions

During an interview with a trained psychologist, the presence of acute stress will be assessed by the SASRQ test within one week of the occurrence of a sudden recovered death. The diagnosis of acute post-traumatic stress disorder is made according to the presence of at least three dissociative symptoms out of five, and other symptoms of re-experiencing, avoidance or marked anxiety or hypervigilance. Each symptom is thus evaluated dichotomously. A symptom is present if the intensity of the response is 3 or more (0 "from 0 to 2" and 1 "from 3 to 5").

Patient and relatives

This questionnaire will be completed during an interview with a psychologist trained in the protocol, 3 months after the sudden death. The PCL-5 is a 20-item self-report questionnaire that assesses the 20 symptoms of PTSD according to the DSM-V. It is associated with the LEC-5 questionnaire. The self-reported scale uses ratings of "0 to 4" to assess each of the symptoms. A threshold of 38 on the PCL-5 seems reasonable to suggest the presence of PTSD.

Patient and relatives

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with resuscitated sudden cardiac death and/or their relative
  • Patients who are fluent in French
  • Patients who have given their 'no objection to participation to the research'
  • Patients of both gender over 18 years
  • Women with childbearing potential and effective contraception

You may not qualify if:

  • People who are not able to give their 'no objection to participate to the research'
  • People with major cognitive disorders post sudden cardiac death
  • People with known psychiatric disorder
  • Women who are known to be pregnant or lactating
  • Person deprived of liberty by judicial or administrative decision
  • People under legal protection (under the protection of a conservator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bordeaux University Hospital

Pessac, 33604, France

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersHeart ArrestHeart DiseasesCardiovascular DiseasesDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Adeline Banos

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: 40 participants (20 patients and 20 relatives)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2021

First Posted

June 10, 2021

Study Start

May 18, 2021

Primary Completion

September 26, 2022

Study Completion

September 26, 2022

Last Updated

June 17, 2025

Record last verified: 2025-06

Locations